Prevention of chronic renal allograft rejection by SERP-1 protein

Eric L.R. Bédard, Jifu Jiang, Jacqueline Arp, Hua Qian, Hao Wang, Haiyan Guan, Liying Liu, Neil Parry, Peter Kim, Bertha Garcia, Xing Li, Colin Macaulay, Douglas McFadden, Alexandra Lucas, Robert Zhong

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background. In previous studies we have demonstrated that Serp-1, a myxoma virus encoded serine protease inhibitor, dramatically inhibits neointimal hyperplasia in vascular injury and aortic transplant models. Here we examined the effect of peritransplant Serp-1 administration on chronic renal allograft rejection. Methods. Rat renal transplants were performed with sequential recipient sacrifice on postoperative days 2, 10 and 140 to examine both the acute and chronic effects of Serp-1 in recipient rats. Results. Serp-1 administration reduced early posttransplant injury (POD 2) with less acute tubular and vascular necrosis. This translated into a reduction of the characteristic late stage changes of chronic rejection (POD 140), with significantly decreased glomerulosclerosis and neointimal hyperplasia. Effects of Serp-1 treatment were already evident as early as POD 2 with markedly decreased levels of TGF-β mRNA witnessed at both the early and late time points (POD 2, 10 and 140). Conclusion. We have demonstrated that peritransplant Serp-1 viral protein decreased early injury and allowed reduced chronic rejection in a rat renal model. Recipients treated with Serp-1 are associated with a decrease in TGF-β mRNA levels in the allografts suggesting that the serine protease inhibitor may inhibit TGF-β transcription and its profibrotic effects.

Original languageEnglish (US)
Pages (from-to)908-914
Number of pages7
JournalTransplantation
Volume81
Issue number6
DOIs
StatePublished - Mar 1 2006
Externally publishedYes

Fingerprint

Allografts
Serine Proteinase Inhibitors
Kidney
Hyperplasia
Myxoma virus
Transplants
Messenger RNA
Proteins
Vascular System Injuries
Wounds and Injuries
Viral Proteins
Blood Vessels
Necrosis

Keywords

  • Chronic
  • Kidney
  • Rat
  • Rejection
  • SERP-1

ASJC Scopus subject areas

  • Transplantation

Cite this

Bédard, E. L. R., Jiang, J., Arp, J., Qian, H., Wang, H., Guan, H., ... Zhong, R. (2006). Prevention of chronic renal allograft rejection by SERP-1 protein. Transplantation, 81(6), 908-914. https://doi.org/10.1097/01.tp.0000203141.02725.8a

Prevention of chronic renal allograft rejection by SERP-1 protein. / Bédard, Eric L.R.; Jiang, Jifu; Arp, Jacqueline; Qian, Hua; Wang, Hao; Guan, Haiyan; Liu, Liying; Parry, Neil; Kim, Peter; Garcia, Bertha; Li, Xing; Macaulay, Colin; McFadden, Douglas; Lucas, Alexandra; Zhong, Robert.

In: Transplantation, Vol. 81, No. 6, 01.03.2006, p. 908-914.

Research output: Contribution to journalArticle

Bédard, ELR, Jiang, J, Arp, J, Qian, H, Wang, H, Guan, H, Liu, L, Parry, N, Kim, P, Garcia, B, Li, X, Macaulay, C, McFadden, D, Lucas, A & Zhong, R 2006, 'Prevention of chronic renal allograft rejection by SERP-1 protein', Transplantation, vol. 81, no. 6, pp. 908-914. https://doi.org/10.1097/01.tp.0000203141.02725.8a
Bédard ELR, Jiang J, Arp J, Qian H, Wang H, Guan H et al. Prevention of chronic renal allograft rejection by SERP-1 protein. Transplantation. 2006 Mar 1;81(6):908-914. https://doi.org/10.1097/01.tp.0000203141.02725.8a
Bédard, Eric L.R. ; Jiang, Jifu ; Arp, Jacqueline ; Qian, Hua ; Wang, Hao ; Guan, Haiyan ; Liu, Liying ; Parry, Neil ; Kim, Peter ; Garcia, Bertha ; Li, Xing ; Macaulay, Colin ; McFadden, Douglas ; Lucas, Alexandra ; Zhong, Robert. / Prevention of chronic renal allograft rejection by SERP-1 protein. In: Transplantation. 2006 ; Vol. 81, No. 6. pp. 908-914.
@article{06f6568099874f9885d7bbe0506a22c1,
title = "Prevention of chronic renal allograft rejection by SERP-1 protein",
abstract = "Background. In previous studies we have demonstrated that Serp-1, a myxoma virus encoded serine protease inhibitor, dramatically inhibits neointimal hyperplasia in vascular injury and aortic transplant models. Here we examined the effect of peritransplant Serp-1 administration on chronic renal allograft rejection. Methods. Rat renal transplants were performed with sequential recipient sacrifice on postoperative days 2, 10 and 140 to examine both the acute and chronic effects of Serp-1 in recipient rats. Results. Serp-1 administration reduced early posttransplant injury (POD 2) with less acute tubular and vascular necrosis. This translated into a reduction of the characteristic late stage changes of chronic rejection (POD 140), with significantly decreased glomerulosclerosis and neointimal hyperplasia. Effects of Serp-1 treatment were already evident as early as POD 2 with markedly decreased levels of TGF-β mRNA witnessed at both the early and late time points (POD 2, 10 and 140). Conclusion. We have demonstrated that peritransplant Serp-1 viral protein decreased early injury and allowed reduced chronic rejection in a rat renal model. Recipients treated with Serp-1 are associated with a decrease in TGF-β mRNA levels in the allografts suggesting that the serine protease inhibitor may inhibit TGF-β transcription and its profibrotic effects.",
keywords = "Chronic, Kidney, Rat, Rejection, SERP-1",
author = "B{\'e}dard, {Eric L.R.} and Jifu Jiang and Jacqueline Arp and Hua Qian and Hao Wang and Haiyan Guan and Liying Liu and Neil Parry and Peter Kim and Bertha Garcia and Xing Li and Colin Macaulay and Douglas McFadden and Alexandra Lucas and Robert Zhong",
year = "2006",
month = "3",
day = "1",
doi = "10.1097/01.tp.0000203141.02725.8a",
language = "English (US)",
volume = "81",
pages = "908--914",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Prevention of chronic renal allograft rejection by SERP-1 protein

AU - Bédard, Eric L.R.

AU - Jiang, Jifu

AU - Arp, Jacqueline

AU - Qian, Hua

AU - Wang, Hao

AU - Guan, Haiyan

AU - Liu, Liying

AU - Parry, Neil

AU - Kim, Peter

AU - Garcia, Bertha

AU - Li, Xing

AU - Macaulay, Colin

AU - McFadden, Douglas

AU - Lucas, Alexandra

AU - Zhong, Robert

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Background. In previous studies we have demonstrated that Serp-1, a myxoma virus encoded serine protease inhibitor, dramatically inhibits neointimal hyperplasia in vascular injury and aortic transplant models. Here we examined the effect of peritransplant Serp-1 administration on chronic renal allograft rejection. Methods. Rat renal transplants were performed with sequential recipient sacrifice on postoperative days 2, 10 and 140 to examine both the acute and chronic effects of Serp-1 in recipient rats. Results. Serp-1 administration reduced early posttransplant injury (POD 2) with less acute tubular and vascular necrosis. This translated into a reduction of the characteristic late stage changes of chronic rejection (POD 140), with significantly decreased glomerulosclerosis and neointimal hyperplasia. Effects of Serp-1 treatment were already evident as early as POD 2 with markedly decreased levels of TGF-β mRNA witnessed at both the early and late time points (POD 2, 10 and 140). Conclusion. We have demonstrated that peritransplant Serp-1 viral protein decreased early injury and allowed reduced chronic rejection in a rat renal model. Recipients treated with Serp-1 are associated with a decrease in TGF-β mRNA levels in the allografts suggesting that the serine protease inhibitor may inhibit TGF-β transcription and its profibrotic effects.

AB - Background. In previous studies we have demonstrated that Serp-1, a myxoma virus encoded serine protease inhibitor, dramatically inhibits neointimal hyperplasia in vascular injury and aortic transplant models. Here we examined the effect of peritransplant Serp-1 administration on chronic renal allograft rejection. Methods. Rat renal transplants were performed with sequential recipient sacrifice on postoperative days 2, 10 and 140 to examine both the acute and chronic effects of Serp-1 in recipient rats. Results. Serp-1 administration reduced early posttransplant injury (POD 2) with less acute tubular and vascular necrosis. This translated into a reduction of the characteristic late stage changes of chronic rejection (POD 140), with significantly decreased glomerulosclerosis and neointimal hyperplasia. Effects of Serp-1 treatment were already evident as early as POD 2 with markedly decreased levels of TGF-β mRNA witnessed at both the early and late time points (POD 2, 10 and 140). Conclusion. We have demonstrated that peritransplant Serp-1 viral protein decreased early injury and allowed reduced chronic rejection in a rat renal model. Recipients treated with Serp-1 are associated with a decrease in TGF-β mRNA levels in the allografts suggesting that the serine protease inhibitor may inhibit TGF-β transcription and its profibrotic effects.

KW - Chronic

KW - Kidney

KW - Rat

KW - Rejection

KW - SERP-1

UR - http://www.scopus.com/inward/record.url?scp=33645636750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645636750&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000203141.02725.8a

DO - 10.1097/01.tp.0000203141.02725.8a

M3 - Article

C2 - 16570016

AN - SCOPUS:33645636750

VL - 81

SP - 908

EP - 914

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -